Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Quantum
Quantum Cyber sharpens strategic focus to quantum navigation and interceptor drones

The defense technology company is concentrating its System-of-Systems platform on quantum antenna technology, one-way attack drones, and the MAHCA ope...

Blue
Blue announces business combination with Blockfusion

SPAC Blue Acquisition Corp filed an exhibit providing an investor presentation for the proposed merger with Blockfusion USA and Blockfusion Digital In...

C4
C4 Therapeutics Presents Biomarker Data from New Myeloma Trials

C4 Therapeutics presented new biomarker reinforcing the immunomodulatory activity of cemsidomide in combination therapies at the 23rd IMS Annual Meeti...

FACTSET
FactSet appoints Marcel Prins to board

Marcel Prins, formerly COO at Robeco, will join FactSet's board effective September 25, 2026, to support its AI and digital strategy....

Atlas
Atlas Announces Equipment Purchase Agreements With AI Lab

Atlas Energy Solutions Inc. announced separate equipment purchase agreements backed by cost reimbursement arrangements for data center power projects,...

Duke
Duke Energy appoints Joyce Mullen to board

Effective Sept. 28, Duke Energy appointed Joyce Mullen to its board of directors, adding a leader with AI and digital transformation experience to its...

FERRELLGAS
Ferrellgas Reports Fiscal 2026 Results

Ferrellgas Partners reported real momentum in fiscal 2026 earnings, marked by the conversion of Class B Units into Class A Units and credit rating upg...

Tamboran
Tamboran reveals 4Q FY26 results via CEO presentation

Tamboran Resources Corp released its 4Q FY26 results presentation featuring CEO Todd Abbott on September 25, 2026. The filing contains forward-looking...

MRNA
Why is Moderna (MRNA) Stock Trending After Hours?

Why is Moderna (MRNA) Stock Trending After Hours?...

WMT
Elizabeth Warren Says Walmart Patent Could Jack Up Mayo Price the Second Tuna Hits Your Cart: Patented Tech Makes 'Surveillance Pricing' Possible

Elizabeth Warren Says Walmart Patent Could Jack Up Mayo Price the Second Tuna Hits Your Cart: Patented Tech Makes 'Surveillance Pricing' Possible...

DAL
US Airlines Oppose More China-US Flights as Xi Jinping Pushes for Expanded Air Links: Report

US Airlines Oppose More China-US Flights as Xi Jinping Pushes for Expanded Air Links: Report...

META
Meta’s AI Spending Suddenly Makes Sense

Meta’s AI Spending Suddenly Makes Sense...

AAPL
Understanding Apple's Position In Technology Hardware, Storage & Peripherals Industry Compared To Competitors

Understanding Apple's Position In Technology Hardware, Storage & Peripherals Industry Compared To Competitors...

NKE
B of A Securities Downgrades Nike to Underperform, Lowers Price Target to $30

B of A Securities Downgrades Nike to Underperform, Lowers Price Target to $30...

MRK
Merck Receives FDA Approval For Its Dual Oral Regimen Of WELIREG Plus LENMIVA For The Treatment Of Adult Patients With Advanced Renal Cell Carcinoma With A Clear Cell Component

Merck Receives FDA Approval For Its Dual Oral Regimen Of WELIREG Plus LENMIVA For The Treatment Of Adult Patients With Advanced Renal Cell Carcinoma W...

JNJ
Johnson & Johnson Says 50% Of Patients Progression-Free At Five Years After Single Carvykti Infusion In Phase 2 Multiple Myeloma Trial

Johnson & Johnson Says 50% Of Patients Progression-Free At Five Years After Single Carvykti Infusion In Phase 2 Multiple Myeloma Trial...

META
Big Tech’s Data Center Boom Could Be Stopped by One Scarce Resource

Big Tech’s Data Center Boom Could Be Stopped by One Scarce Resource...

MSFT
JD Vance Warns Companies Against 'Cheap' H-1B Replacements: 'We're Not Going to Let You Lay Off American Workers'

JD Vance Warns Companies Against 'Cheap' H-1B Replacements: 'We're Not Going to Let You Lay Off American Workers'...

PG
Italian Regulator Closes Investigation Into Procter & Gamble's Hair Removal Device

Italian Regulator Closes Investigation Into Procter & Gamble's Hair Removal Device...

JNJ
Johnson & Johnson Announces That TREMFYA Met Primary And Major Secondary Endpoints Demonstrating Both Improvement In Axial Symptoms And Reduction In Inflammation By MRI Assessment In The Phase 4 STAR Study Evaluating Biologic-Naïve Adults With Active Psoriatic Arthritis And Axial Involvement

Johnson & Johnson Announces That TREMFYA Met Primary And Major Secondary Endpoints Demonstrating Both Improvement In Axial Symptoms And Reduction In I...